Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.74NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.74NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.12NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.12NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.258.14NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.14NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FL.17.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.17.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.23NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.23NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.562NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.562NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.219NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.219NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.338NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.338NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BG.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BG.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.20.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.20.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XVNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XVNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.38.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.38.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.4.1.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.4.1.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.22NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.22NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.70NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.70NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.42NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.42NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.428NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.428NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.374NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.374NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.63 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.63 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.31NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.31NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.385NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.385NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.384NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.384NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.32NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.32NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CW.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used